All Photos(1)

Documents

1500240

USP

Paroxetine Related Compound C

Name: Paroxetine Related Compound C
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

(3R-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate

Sign Into View Organizational & Contract Pricing

All Photos(1)

About This Item

Empirical Formula (Hill Notation):

C₁₉H₂₀FNO₃ · HCl · 0.5H₂O

Molecular Weight:

374.83

UNSPSC Code:

41116107

NACRES:

NA.24

Recommended Products

Slide 1 of 9

1 of 9

Y0000233

Paroxetine impurity A

USP

1500218

Paroxetine hydrochloride

USP

1500230

Paroxetine Related Compound B

BP1024

Paroxetine hydrochloride hemihydrate

BP746

Paroxetine impurity standard

Millipore

MMSMCRA48

Milliflex Oasis^® Culture Media Plate

MCF7 Cell Line human

Y0000281

Paroxetine hydrochloride hemihydrate

USP

1559647

Pregabalin Related Compound C

grade

pharmaceutical primary standard

API family

paroxetine

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analytical Reference Standards

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Paroxetine Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monograph such as Paroxetine Hydrochloride.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

related product

Product No.

Description

Pricing

1500230

1500251

1500284

Y0000579

Paroxetine hydrochloride (anhydrous) impurity C, European Pharmacopoeia (EP) Reference Standard

PHR1804

Paroxetine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

BP1024

Paroxetine hydrochloride hemihydrate, British Pharmacopoeia (BP) Reference Standard

BP746

Paroxetine impurity standard, British Pharmacopoeia (BP) Reference Standard

PHR3076

pictograms

GHS05

signalword

Danger

hcodes

H318

pcodes

P280 - P305 + P351 + P338 + P310

Hazard Classifications

Eye Dam. 1

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

New validated HPLC methodology for the determination of (-)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase.

Małgorzata Lisowska-Kuźmicz et al.

Analytical and bioanalytical chemistry, 406(15), 3697-3702 (2014-01-11)

A new chromatographic method for the enantioseparation and the determination of (-)-trans-paroxetine and (+)-trans-paroxetine has been developed with the aid of amylose ovomucoid-based chiral stationary phase. The method is faster and five times more sensitive than procedures recommended previously: limit

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service